Stelios Papadopoulos - 11 May 2021 Form 4 Insider Report for EXELIXIS, INC. (EXEL)

Role
Director
Signature
/s/ Jennifer Drimmer Rokovich, Attorney in Fact
Issuer symbol
EXEL
Transactions as of
11 May 2021
Net transactions value
-$6,394
Form type
4
Filing time
13 May 2021, 20:32:31 UTC
Next filing
28 May 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXEL Common Stock Options Exercise $252,000 +40,000 +3.4% $6.30 1,228,897 11 May 2021 Direct F1
transaction EXEL Common Stock Sale $255,039 -10,222 -0.83% $24.95 1,218,675 11 May 2021 Direct F2
transaction EXEL Common Stock Options Exercise $125,200 +40,000 +3.3% $3.13* 1,258,675 11 May 2021 Direct
transaction EXEL Common Stock Sale $126,875 -5,075 -0.4% $25.00 1,253,600 11 May 2021 Direct F3
transaction EXEL Common Stock Options Exercise $135,200 +40,000 +3.2% $3.38* 1,293,600 11 May 2021 Direct
transaction EXEL Common Stock Sale $136,880 -5,473 -0.42% $25.01 1,288,127 11 May 2021 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXEL Option (right to buy) Options Exercise $0 -40,000 -100% $0.000000* 0 11 May 2021 Common Stock 40,000 $6.30 Direct F5
transaction EXEL Option (right to buy) Options Exercise $0 -40,000 -100% $0.000000* 0 11 May 2021 Common Stock 40,000 $3.13 Direct F6
transaction EXEL Option (right to buy) Options Exercise $0 -40,000 -100% $0.000000* 0 11 May 2021 Common Stock 40,000 $3.38 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 15,538 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units.
F2 Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $24.93 to $24.97. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
F3 Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $24.98 to $25.01. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.
F4 Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $24.99 to $25.01. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4.
F5 The option, representing the right to purchase a total of 40,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 26, 2016.
F6 The option, representing the right to purchase a total of 40,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 28, 2015.
F7 The option, representing the right to purchase a total of 40,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 29, 2014.